Your browser doesn't support javascript.
loading
Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study.
Bogani, Giorgio; Papadia, Andrea; Buda, Alessandro; Casarin, Jvan; Di Donato, Violante; Gasparri, Maria Luisa; Plotti, Francesco; Pinelli, Ciro; Paderno, Maria Chiara; Lopez, Salvatore; Perrone, Anna Myriam; Barra, Fabio; Guerrisi, Rocco; Brusadelli, Claudia; Cromi, Antonella; Ferrari, Debora; Chiapp, Valentina; Signorelli, Mauro; Leone Roberti Maggiore, Umberto; Ditto, Antonino; Palaia, Innocenza; Ferrero, Simone; De Iaco, Pierandrea; Angioli, Roberto; Panici, Pierluigi Benedetti; Ghezzi, Fabio; Landoni, Fabio; Mueller, Michael D; Raspagliesi, Francesco.
Afiliação
  • Bogani G; Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy. Electronic address: Giorgio.bogani@istitutotumori.mi.it.
  • Papadia A; Department of Obstetrics and Gynecology, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale, University' of Italian Switzerland, Lugano, Switzerland.
  • Buda A; Gynecology Oncology Surgical Unit, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
  • Casarin J; Department of Obstetrics and Gynecology, 'Filippo Del Ponte' Hospital, University of Insubria, Italy.
  • Di Donato V; Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Italy.
  • Gasparri ML; Department of Obstetrics and Gynecology, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale, University' of Italian Switzerland, Lugano, Switzerland.
  • Plotti F; Department of Obstetrics and Gynecology, University Campus Biomedico of Rome, Rome, Italy.
  • Pinelli C; Department of Obstetrics and Gynecology, 'Filippo Del Ponte' Hospital, University of Insubria, Italy.
  • Paderno MC; Gynecology Oncology Surgical Unit, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
  • Lopez S; Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy.
  • Perrone AM; Gynecologic Oncology Unit, Sant'Orsola-Malpighi Hospital, 40138 Bologna, Italy.
  • Barra F; Academic Unit of Obstetrics and Gynaecology, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Guerrisi R; Department of Obstetrics and Gynecology, 'Filippo Del Ponte' Hospital, University of Insubria, Italy. Electronic address: rocco@guerrisi.it.
  • Brusadelli C; Department of Obstetrics and Gynecology, 'Filippo Del Ponte' Hospital, University of Insubria, Italy.
  • Cromi A; Department of Obstetrics and Gynecology, 'Filippo Del Ponte' Hospital, University of Insubria, Italy.
  • Ferrari D; Gynecology Oncology Surgical Unit, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
  • Chiapp V; Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy.
  • Signorelli M; Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy.
  • Leone Roberti Maggiore U; Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy.
  • Ditto A; Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy.
  • Palaia I; Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Italy.
  • Ferrero S; Academic Unit of Obstetrics and Gynaecology, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genova, Italy.
  • De Iaco P; Department of Obstetrics and Gynecology, University Campus Biomedico of Rome, Rome, Italy.
  • Angioli R; Department of Obstetrics and Gynecology, University Campus Biomedico of Rome, Rome, Italy.
  • Panici PB; Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Italy.
  • Ghezzi F; Department of Obstetrics and Gynecology, 'Filippo Del Ponte' Hospital, University of Insubria, Italy.
  • Landoni F; Gynecology Oncology Surgical Unit, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
  • Mueller MD; Department of Obstetrics and Gynecology, University Hospital of Bern and University of Bern, Bern, Switzerland.
  • Raspagliesi F; Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy.
Gynecol Oncol ; 161(1): 122-129, 2021 04.
Article em En | MEDLINE | ID: mdl-33485641
ABSTRACT

OBJECTIVE:

Sentinel node mapping (SLN) has replaced lymphadenectomy for staging surgery in apparent early-stage low and intermediate risk endometrial cancer (EC). Only limited data about the adoption of SNM in high risk EC is still available. Here, we evaluate the outcomes of high-risk EC undergoing SNM (with or without back-up lymphadenectomy).

METHODS:

This is a multi-institutional international retrospective study, evaluating data of high-risk (FIGO grade 3 endometrioid EC with myometrial invasion >50% and non-endometrioid histology) EC patients undergoing SNM followed by back-up lymphadenectomy and SNM alone.

RESULTS:

Chart of consecutive 196 patients were evaluated. The study population included 83 and 113 patients with endometrioid and non-endometrioid EC, respectively. SNM alone and SNM followed by back-up lymphadenectomy were performed in 50 and 146 patients, respectively. Among patients having SNM alone, 14 (28%) were diagnosed with nodal disease. In the group of patients undergoing SNM plus back-up lymphadenectomy 34 (23.2%) were diagnosed with nodal disease via SNM. Back-up lymphadenectomy identified 2 (1%) additional patients with nodal disease (in the para-aortic area). Back-up lymphadenectomy allowed to remove adjunctive positive nodes in 16 (11%) patients. After the adoption of propensity-matched algorithm, we observed that patients undergoing SNM plus back-up lymphadenectomy experienced similar disease-free survival (p = 0.416, log-rank test) and overall survival (p = 0.940, log-rank test) than patients undergoing SLN alone.

CONCLUSIONS:

Although the small sample size, and the retrospective study design this study highlighted that type of nodal assessment did not impact survival outcomes in high-risk EC. Theoretically, back-up lymphadenectomy would be useful in improving the removal of positive nodes, but its therapeutic value remains controversial. Further prospective evidence is needed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Biópsia de Linfonodo Sentinela / Linfonodos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Biópsia de Linfonodo Sentinela / Linfonodos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2021 Tipo de documento: Article